At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,935 enrolled
Drug / intervention
Investigational Product +3 morecombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Antimicrobial Effectiveness of CHG/IPA in Healthy Volunteers
In Brief
A clinical study evaluating Investigational Product, Reference Standard, and 2 other interventions for Microbial Colonization. Completed, enrolled 1,935 participants across 1 site.
Detailed Summary
This single site study is a randomized, controlled, partially-blinded design enrolling a minimum of 516 healthy volunteers, where each subject will receive two of the planned study products on the product application sites of the abdomen and/or groin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMicrobial Colonization
CountriesRomania
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartApr 2019
First PostedJul 2019
Primary CompletionDec 2019
TodayJul 2026
First PostedJul 29, 2019
Enrollment StartApr 17, 2019
Primary CompletionDec 24, 2019
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 6.9 years ago
Interventions
Investigational Productcombination
2%(w/v) Chlorhexidine in 70%(v/v) Isopropyl skin preparation
Reference Standardother
60% (v/v) 1-propanol skin preparation
Active Comparatorcombination
ChloraPrep® SEPP® skin preparation
Negative Controlother
0.9% Normal Saline skin preparation